NCT03367221

Brief Summary

Primary Graft Dysfunction (PGD) respresents the leading cause of mortality in early post-operative period of Lung Tranplantation (LTx). Protective ventilatory strategy could potentially reduce the risk of PGD in these patients. Neurally Adjusted Ventilatory Assist (NAVA) is an assisted ventilation mode that could allow to adopt this strategy. Aim of the study is to assess the feasibility of NAVA in the early post-LTx phase and to describe the breathing pattern and the physiological relationship between neural respiratory drive and different levels of ventilatory assist, in the absence of pulmonary vagal afferent feedback.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
2 countries

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 23, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 24, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 8, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

December 8, 2017

Status Verified

December 1, 2017

Enrollment Period

1.9 years

First QC Date

November 24, 2017

Last Update Submit

December 7, 2017

Conditions

Outcome Measures

Primary Outcomes (5)

  • Evaluation of the variations of Electrical Activity of the Diaphragm in response to different levels of ventilatory assist at different degrees of lung inflation (different Positive End Expiratory Pressure values)

    Electrical Activity of the Diaphragm (EAdi) (microVolt)

    One hour after the recovery of spontaneous breathing

  • Evaluation of the variations of Neuro-Mechanical Coupling (expressed as microVolt of EAdi /cmH2O of airway pressure Ratio) in response to different levels of ventilatory assist at different degrees of lung inflation

    Neuro-Mechanical Coupling (NMC) (microvolt/cmH2O)

    One hour after the recovery of spontaneous breathing

  • Evaluation of the variations of Neuro-ventilatory Efficiency (expressed as microvolt of EAdi / mL of Tidal Volume Ratio) in response to different levels of ventilatory assist at different degree of lung inflation

    Neuro-Ventilatory Efficiency (NVE) (microvolt/mL)

    One hour after the recovery of spontaneous breathing

  • Evaluation of the changes in the patient's neural breathing pattern (expressed as mL of Tidal Volume) at different levels of ventilatory assist

    Tidal Volume (mL)

    One hour after the recovery of spontaneous breathing

  • Evaluation of the changes in the patient's neural breathing pattern (expressed as respiratory rate) at different levels of ventilatory assist

    Respiratory rate (Breaths/min)

    One hour after the recovery of spontaneous breathing

Secondary Outcomes (3)

  • Evaluation of the feasibility of Plateau Pressure during NAVA

    One hour after the recovery of spontaneous breathing, with inspiratory hold manoeuvres

  • Ultrasound assessment of the changes of Diaphragm's Thickening Fraction at different levels of Positive End Expiratory Pressure and at different NAVA gains

    One hour after the recovery of spontaneous breathing

  • Assesment of the total asynchrony index (double triggering + missed efforts + inspiratory trigger delay +short cycling + prolonged cycling)

    One hour after the recovery of spontaneous breathing

Study Arms (1)

NAVA group

EXPERIMENTAL

NAVA ventilation

Device: NAVA ventilation

Interventions

Assisted Ventilation Mode, synchronized, through EAdi catheter, with patient's inspiratory effort and proportional to respiratory drive

NAVA group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 y.o.
  • Admission to ICU for post-operative monitoring after LTx
  • Presence of spontaneous breathing activity
  • Sedation titrated to a target RASS between 0 and -2
  • Written informed consent obtained

You may not qualify if:

  • Contraindication to nasogastric tube insertion (gastroesophageal surgery in the previous 3 months, gastroesophageal bleeding in the previous 30 days, history of esophageal varices, facial trauma)
  • Increased risk of bleeding with nasogastric tube insertion, due to severe coagulation disorders and severe thrombocytopenia ( i.e., INR \> 2 and platelets count \< 70.000/mm3)
  • Severe hemodynamic instability (noradenaline \> 0.3 μg/kg/min and/or use of vasopressin)
  • Postoperative extracorporeal respiratory support (ECMO)
  • Pre-operative reconditioning of the transplanted lungs by means of ex-vivo lung perfusion (EVLP)
  • Lung retransplantation
  • Failure to obtain a stable EAdi signal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ospedale Maggiore Policlinico

Milan, 20122, Italy

RECRUITING

University Hospital of Lausanne

Lausanne, 10111, Switzerland

RECRUITING

Related Publications (1)

  • Grasselli G, Castagna L, Abbruzzese C, Corcione N, Bottino N, Guzzardella A, Colombo SM, Carlesso E, Mauri T, Rossetti V, Palleschi A, Scaravilli V, Zanella A, Pesenti A. Pulmonary volume-feedback and ventilatory pattern after bilateral lung transplantation using neurally adjusted ventilatory assist ventilation. Br J Anaesth. 2021 Jul;127(1):143-152. doi: 10.1016/j.bja.2021.03.010. Epub 2021 Apr 21.

MeSH Terms

Conditions

Ventilator-Induced Lung Injury

Condition Hierarchy (Ancestors)

Lung InjuryLung DiseasesRespiratory Tract Diseases

Study Officials

  • Chiara Abbruzzese, MD

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    PRINCIPAL INVESTIGATOR
  • Luigi Castagna, MD

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    PRINCIPAL INVESTIGATOR
  • Nicola Bottino, MD

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    PRINCIPAL INVESTIGATOR
  • Alberto Zanella, MD

    University of Milan

    PRINCIPAL INVESTIGATOR
  • Nadia Corcione, MD

    Fondazione IRCCS Ca' Granda

    PRINCIPAL INVESTIGATOR
  • Antonio Pesenti, Prof

    University of Milan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Giacomo Grasselli, Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

November 24, 2017

First Posted

December 8, 2017

Study Start

November 23, 2017

Primary Completion

November 1, 2019

Study Completion

November 1, 2019

Last Updated

December 8, 2017

Record last verified: 2017-12

Locations